154 related articles for article (PubMed ID: 2676168)
1. [Hemodynamic effects of the intravenous administration of captopril in patients with chronic congestive heart failure].
Volpini M; Gargano M; Cuccia C; Dei Cas L; Gei P; Metra M; Moretti R; Riva S
Cardiologia; 1989 Jun; 34(6):517-23. PubMed ID: 2676168
[TBL] [Abstract][Full Text] [Related]
2. [Hemodynamic and clinical effects of captopril in congestive heart failure].
Galiè N; Magelli C; Ribani MA; Bassein L; Sanguinetti M; Magnani B
G Ital Cardiol; 1985 Jan; 15(1):70-9. PubMed ID: 3891488
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic and clinical effects of captopril in patients with severe congestive heart failure.
Nigri A; Mangieri E; Martuscelli E; Danesi A; Sardella G; Berni A; Sardella F
Cardiologia; 1989 Jun; 34(6):525-9. PubMed ID: 2676169
[TBL] [Abstract][Full Text] [Related]
4. Acute and long-term hemodynamic effects of pimobendan (UD-CG 115 BS) in comparison with captopril.
Hauf GF; Grom E; Jähnchen E; Roskamm H
J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S49-56. PubMed ID: 2478793
[TBL] [Abstract][Full Text] [Related]
5. [The acute, chronic continuous after treatment and chronic intermittent with a variable therapeutic window (4 and 6 hours) hemodynamic effects induced with transdermal nitroglycerin in patients with congestive heart failure].
Nodari S; Metra M; Gei P; Danesi R; Furloni R; Cuminetti S; Dei Cas L
Cardiologia; 1991 Jun; 36(6):451-60. PubMed ID: 1769029
[TBL] [Abstract][Full Text] [Related]
6. [Long-term treatment of chronic heart failure by an inhibitor of angiotensin converting enzyme].
Komajda M; Eugène M; Evans J; Laurenceau JL; Hubermann JP; Thomas D; Drobinski G; Leprince JL; Ganty J; Wajman A; Guedj D; Grosgogeat Y
Arch Mal Coeur Vaiss; 1983 Jan; 76(1):29-36. PubMed ID: 6303239
[TBL] [Abstract][Full Text] [Related]
7. [Hemodynamic and clinical effects and treatment tolerance with low-dose iv amrinone in patients with refractory heart failure: a multicenter study. The Group for Research on Amrinone in the Treatment of Refractory Heart Failure].
Dei Cas L; Metra M; Nodari S; Raddino R; Visioli O
Cardiologia; 1991 May; 36(5):363-71. PubMed ID: 1756541
[TBL] [Abstract][Full Text] [Related]
8. [Hemodynamics after sublingual administration of captopril in severe heart failure. A pilot study].
Haude M; Steffen W; Erbel R; Tschollar W; Belz GG; Meyer J
Dtsch Med Wochenschr; 1989 Jul; 114(28-29):1095-100. PubMed ID: 2663409
[TBL] [Abstract][Full Text] [Related]
9. [Acute changes in the hemodynamic profile and circulating levels of atrial natriuretic peptide induced by dobutamine in severe heart failure].
La Vecchia L; Bottero M; Centofante P; Bedogni F; Ometto R; Cera A; Fortunato A
G Ital Cardiol; 1996 Aug; 26(8):863-74. PubMed ID: 9005168
[TBL] [Abstract][Full Text] [Related]
10. Effects of captopril in heart failure complicating acute myocardial infarction and persistence of acute haemodynamic effects in chronic heart failure after 3 years of treatment.
Mattioli G; Ricci S; Rigo R; Fusaro MT; Cappello C
Postgrad Med J; 1986; 62 Suppl 1():164-6. PubMed ID: 3534855
[TBL] [Abstract][Full Text] [Related]
11. [Acute hemodynamic effects of pimobendan and captopril: a comparative study in the same patients with chronic heart failure].
Tsuda T; Izumi T; Kodama M; Hanawa H; Ohshima M; Takahashi M; Suzuki M; Aizaki T; Uchiyama H; Shibata A
J Cardiol; 1992; 22(4):721-9. PubMed ID: 1343639
[TBL] [Abstract][Full Text] [Related]
12. [Neurohumoral and hemodynamic effects in combination therapy of enoximone and dopamine].
Mitrovic V; Neuzner J; Opper H; Thormann J; Schlepper M
Z Kardiol; 1994; 83 Suppl 2():37-48. PubMed ID: 8091823
[TBL] [Abstract][Full Text] [Related]
13. [Acute hemodynamic and coronary effects of captopril in chronic cardiac failure].
Ourbak P; Pornin M; Melanidis J; Bouziri S; Allal J; Sellier P; Maurice P
Arch Mal Coeur Vaiss; 1984 Aug; 77(8):865-71. PubMed ID: 6435565
[TBL] [Abstract][Full Text] [Related]
14. Effects of acetylsalicylic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors.
van Wijngaarden J; Smit AJ; de Graeff PA; van Gilst WH; van der Broek SA; van Veldhuisen DJ; Lie KI; Wesseling H
J Cardiovasc Pharmacol; 1994 Feb; 23(2):240-5. PubMed ID: 7511753
[TBL] [Abstract][Full Text] [Related]
15. [Precapillary pulmonary hypertension: effect of Captopril].
Sanguinetti M; Galiè N; Magelli C; Orselli L; Magnani B
G Ital Cardiol; 1982; 12(6):436-41. PubMed ID: 6761221
[TBL] [Abstract][Full Text] [Related]
16. [Determination of the optimal dose of captopril in the treatment of severe cardiac failure by hourly hemodynamic monitoring].
Allal J; Pornin M; Rossi F; Poupet JY; Bordage JP; Barraine R
Arch Mal Coeur Vaiss; 1984 Apr; 77(4):458-67. PubMed ID: 6426432
[TBL] [Abstract][Full Text] [Related]
17. [Hemodynamic effects of one administration of l-dopa in patients with left ventricular heart failure (introductory remarks)].
Leszek P; Zieliński T; Korewicki J
Kardiol Pol; 1993 May; 38(5):335-9. PubMed ID: 8366641
[TBL] [Abstract][Full Text] [Related]
18. Treatment of chronic congestive heart failure with captopril, an oral inhibitor of angiotensin-converting enzyme.
Davis R; Ribner HS; Keung E; Sonnenblick EH; LeJemtel TH
N Engl J Med; 1979 Jul; 301(3):117-21. PubMed ID: 221810
[TBL] [Abstract][Full Text] [Related]
19. Advantage of combined therapy with captopril and nitrates in severe congestive heart failure.
Halon DA; Rosenfeld T; Hardoff R; Lewis BS
Isr J Med Sci; 1988 Nov; 24(11):664-70. PubMed ID: 3063685
[TBL] [Abstract][Full Text] [Related]
20. [Enhancement of the effect of captopril in the 1st 48 hours of treating refractory heart failure. A comparison with intravenous trinitrine].
Le Pailleur C; Baubion N; Metzger JP; Heulin A; Vacheron A; Di Matteo J
Arch Mal Coeur Vaiss; 1984 Jun; 77(6):700-6. PubMed ID: 6431936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
